Document is current
Any future updates will be listed below
-
Authors
Maharjan, Sushila https://orcid.org/0000-0003-3957-3976
Yamashita, Camila https://orcid.org/0000-0003-0957-1689
Lee, Cheng Pau https://orcid.org/0000-0002-4924-8467
Villalobos Zepeda, Alejandro
Michel Farias, Ana Karen
Duarte Rivera, Andrea https://orcid.org/0000-0002-0266-3540
Aguilar Rojas, Francisco Javier
Rendon Ruiz, David Sebastian
Martinez Hernandez, Armando
Hernandez Medina, David Hyram
Garciamendez-Mijares, Carlos Ezio
Japo, Julia
Bermea Jimenez, Ludivina
Golombek, Sonia
Bentivogli, Alessandro
Hashimoto, Michinao https://orcid.org/0000-0002-9684-2354
Zhang, Yu Shrike https://orcid.org/0000-0002-0045-0808
-
Funding
Funding for this research was provided by:
BWH | Brigham Research Institute
- License Information
-
More Information
Article History
Received: 12 September 2024
Accepted: 8 July 2025
First Online: 28 July 2025
Competing interests
: YSZ consulted for Allevi by 3D Systems; cofounded, consults for, and holds options of Linton Lifesciences; and sits on the scientific advisory board and holds options of Xellar. The relevant interests are managed by the Brigham and Women’s Hospital. The other authors declare no competing interests.
